 SEATTLE, Oct. 06, 2021 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Nasdaq: ADPT, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 